中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
22期
168-169,171
,共3页
糖尿病%糖皮质激素%胰岛素
糖尿病%糖皮質激素%胰島素
당뇨병%당피질격소%이도소
Diabetes%Glucocorticoid%Insulin
目的:观察2型糖尿病患者静滴糖皮质激素期间血糖的变化情况。方法2型糖尿病患者(合并需要使用糖皮质激素的其他疾病)43例,随机分成观察组22例与对照组21例,观察组在静滴糖皮质激素液体中加入胰岛素控制血糖波动;对照组静滴糖皮质激素液体时不加入胰岛素,根据血糖波动情况追加使用胰岛素。观察两组治疗后血糖波动情况及胰岛素用量。结果观察组血糖升高幅度较对照组显著下降,血糖波动低于对照组(P<0.01);观察组胰岛素用量增加幅度减小,胰岛素增加用量少于对照组(P<0.05)。结论选用胰岛素作为基础降糖治疗,按比例在静脉使用糖皮质激素液体组加入胰岛素,可有效防止血糖过高波动,减小胰岛素用量增加幅度。
目的:觀察2型糖尿病患者靜滴糖皮質激素期間血糖的變化情況。方法2型糖尿病患者(閤併需要使用糖皮質激素的其他疾病)43例,隨機分成觀察組22例與對照組21例,觀察組在靜滴糖皮質激素液體中加入胰島素控製血糖波動;對照組靜滴糖皮質激素液體時不加入胰島素,根據血糖波動情況追加使用胰島素。觀察兩組治療後血糖波動情況及胰島素用量。結果觀察組血糖升高幅度較對照組顯著下降,血糖波動低于對照組(P<0.01);觀察組胰島素用量增加幅度減小,胰島素增加用量少于對照組(P<0.05)。結論選用胰島素作為基礎降糖治療,按比例在靜脈使用糖皮質激素液體組加入胰島素,可有效防止血糖過高波動,減小胰島素用量增加幅度。
목적:관찰2형당뇨병환자정적당피질격소기간혈당적변화정황。방법2형당뇨병환자(합병수요사용당피질격소적기타질병)43례,수궤분성관찰조22례여대조조21례,관찰조재정적당피질격소액체중가입이도소공제혈당파동;대조조정적당피질격소액체시불가입이도소,근거혈당파동정황추가사용이도소。관찰량조치료후혈당파동정황급이도소용량。결과관찰조혈당승고폭도교대조조현저하강,혈당파동저우대조조(P<0.01);관찰조이도소용량증가폭도감소,이도소증가용량소우대조조(P<0.05)。결론선용이도소작위기출강당치료,안비례재정맥사용당피질격소액체조가입이도소,가유효방지혈당과고파동,감소이도소용량증가폭도。
Objective To observe the change of blood glucose in patients with type 2 diabetes during the intravenous drip of glucocorticoid. Methods 43 patients with type 2 diabetes combined with other diseases which were needed to use glucocorticoid were randomly divided into 22 patients of the observation group and 21 patients of the control group. The patients in the observation group were added insulin in the intravenous glucocorticoid liquid to control the blood glucose fluctuations, and the patients in the control group were not added insulin in the intravenous glucocorticoid liquid, while used insulin according to the blood glucose fluctuations. The blood glucose fluctuations and insulin dosage of the two groups were observed after the treatment. Results Compared with the control group, the blood glucose rise of the observation group decreased significantly, and the blood glucose fluctuations of the observation group was lower than that of the control group (P<0.01); The insulin dosage rise of the observation group decreased, and the insulin dosage of the observation group was less than that of the control group(P <0.05). Conclusion Choosing insulin as a basic oral glucose-lowering treatment, adding insulin according to the proportion in the intravenous glucocorticoid liquid, which can effectively prevent the hyperglycemia fluctuation, and reduce the insulin dosage rise.